Routine Infectious Disease Consultation Prior to an Allogeneic Hematopoietic Cell Transplant.
Vera PortilloStavroula Masouridi-LevratYves ChalandonMaria MappouraSarah MorinAnnalisa MarinosciFederica GiannottiAnne-Claire MamezChristian van DeldenDionysios NeofytosPublished in: Open forum infectious diseases (2023)
We are proposing a structured, clearly defined, and comprehensive pretransplant checklist for an effective assessment of infectious disease risks and complications prior to an allogeneic HCT. Further studies or experiences like ours could help to define a global strategy or new models of care to be implemented in HCT centers in the future.
Keyphrases
- infectious diseases
- stem cell transplantation
- bone marrow
- palliative care
- hematopoietic stem cell
- cell cycle arrest
- healthcare
- high dose
- single cell
- cell therapy
- mental health
- clinical practice
- current status
- quality improvement
- human health
- mesenchymal stem cells
- risk factors
- cell death
- pain management
- case control
- risk assessment
- low dose
- affordable care act